Text Size

Lipid Profile of Tenon's Capsule

This study has been completed.
Sponsor:
Information provided by:
Centre Hospitalier Universitaire Dijon
ClinicalTrials.gov Identifier:
NCT01021657
First received: November 27, 2009
Last updated: NA
Last verified: November 2009
History: No changes posted
  Purpose

The purpose of this study is to provide data on the lipid profile of the Tenon's capsule in Human glaucomatous eyes and to establish possible relationships with the short term outcome of filtration surgery.


Condition Intervention
Glaucoma
 Procedure: trabeculectomies, non penetrating deep sclerectomies

Study Type: Observational
Study Design: Observational Model: Cohort
Time Perspective: Prospective
Official Title: Lipid Profile of Tenon's Capsule in Glaucoma Patients

Resource links provided by NLM:

MedlinePlus related topics: Glaucoma
U.S. FDA Resources

Further study details as provided by Centre Hospitalier Universitaire Dijon:

Primary Outcome Measures:
  • To provide data on the lipid profile of the Tenon's capsule in Human glaucomatous eyes and to establish possible relationships with the short term outcome of filtration surgery. [ Time Frame: 6 month later ] [ Designated as safety issue: No ]

Biospecimen Retention:   Samples Without DNA

Eye Tenon's Capsule


Enrollment: 27
Study Start Date: January 2009
Study Completion Date: June 2009
Primary Completion Date: June 2009 (Final data collection date for primary outcome measure)
Groups/Cohorts Assigned Interventions
Glaucoma Procedure: trabeculectomies, non penetrating deep sclerectomies

  Eligibility

Ages Eligible for Study:   18 Years to 90 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population

Patient suffering from Glaucoma

Criteria

Inclusion Criteria:

  • Glaucoma
  • Eligibility for surgery

Exclusion Criteria:

  • Patients without Glaucoma
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT01021657

Locations
France
Ophthalmology Unit CHU Dijon
Dijon, France, 21000
Sponsors and Collaborators
Centre Hospitalier Universitaire Dijon
Investigators
Principal Investigator: Catherine Creuzot-Gracher, MD, PhD Ophthalmology unit CHU Dijon
  More Information

No publications provided

Responsible Party: Professor Catherine Creuzot-Garcher, Ophthalmology Department
ClinicalTrials.gov Identifier: NCT01021657     History of Changes
Other Study ID Numbers: Alain01
Study First Received: November 27, 2009
Last Updated: November 27, 2009
Health Authority: France: Afssaps - Agence française de sécurité sanitaire des produits de santé (Saint-Denis)

Keywords provided by Centre Hospitalier Universitaire Dijon:
Glaucoma
Tenon's Capsule
Lipid profile
Assessment of lipid profile in Tenon's capsule in patients with Glaucoma

Additional relevant MeSH terms:
Glaucoma
Ocular Hypertension
Eye Diseases

ClinicalTrials.gov processed this record on May 16, 2013